by Katie Moisse | Jun 4, 2010
The UK-based Motor Neurone Disease Association has recently funded a £800,000 ($1.2 million) program to study motor neurons derived from the skin cells of amyotrophic lateral sclerosis (ALS) patients with rare, disease-causing mutations in the gene TARBP. Although the...
by Michelle Ly | May 31, 2010
Part one in a series looking at the processes involved in the most clinically applied form of stem cell therapy: hematopoietic stem cell transplantation Leukocytes, or white blood cells (WBCs), are an essential part of the immune system. Produced in the bone marrow,...
by Allison Van Winkle | May 27, 2010
The potential gains from stem cell research are unlimited; stem cells could be used to replace degenerated cells and tissue in the human body. However, the large scale implementation of stem cell therapy to a clinical setting will require the establishment of a...
by Ubaka Ogbogu | May 25, 2010
On April 28, 2010, the Board of Appeals and Interference (BPAI) of the U.S. Patent and Trademark Office (USPTO) reversed an earlier decision that upheld the claims of U.S. Patent Number 7,029,913, one of the trio of patents commonly known as WARF or Thomson patents....
by Chris Kamel | May 20, 2010
One hurdle facing the use of lab-grown stem cells for therapeutic or experimental purposes is the accumulation of genetic abnormalities over time. The nature of these changes varies, but some may affect therapeutic usefulness and many mirror changes seen in...
by Stem Cell Network | May 18, 2010
Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig’s Disease and motor neuron disease (MND), is a progressive neuromuscular disease that attacks nerve cells in the brain and spinal cord. As these neurons slowly waste away, they become unable to transmit signals...
by David Kent | May 17, 2010
After being spoiled with six years’ worth of camaraderie with the stem cell community in Canada via the Stem Cell Network’s annual meeting and countless other interactions, I recently made the journey from Connie Eaves’ lab in Vancouver to pursue post doctoral...
by Paul Krzyzanowski | May 11, 2010
Imagine that you’ve just discovered a novel drug that potentially solves a medical problem, one that accelerates wound healing in skin or can reduce the size of cancerous tumors. You can show the effects beautifully in your model tissue culture system and mice...
by Ubaka Ogbogu | May 6, 2010
The recent resignation of two members of the Board of Directors of Assisted Human Reproduction Canada (AHRC), the federal regulatory agency responsible for implementing the provisions of the Assisted Human Reproduction Act, has once again raised questions regarding...
by Chris Kamel | Apr 29, 2010
In Britain, a young boy is currently recovering from a remarkable surgery to replace his windpipe. Tissue transplantation itself is hardly a routine thing, but there are a couple of things that make this case, reported in the British Medical Journal, particularly...
Comments